Institution statistics

NOVO NORDISK A/S - Denmark 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:700-800
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:500-600
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:900-1000
Total Number of Projects:69
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:700-800
Project Leadership Index:700-800
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:600-700
Project Leadership Index:600-700
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:700-800
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:700-800
Project Leadership Index:700-800
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:600-700
Total Number of Projects:> 1000
Total Project Funding:600-700
Networking Rank (Reputation):> 1000
Partner Constancy:800-900
Project Leadership Index:500-600
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:700-800
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:600-700
Project Leadership Index:600-700
Diversity Index:> 1000
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 24
As coordinator: 0
As participant: 24
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 3.294.917 297.522 1
2020 0 22.458.244 300.000 3
2019 0 40.904.592 0 4
2018 0 25.821.795 290.082 5
2017 0 31.347.714 0 3
2016 0 26.949.452 580.164 3
2015 0 20.276.334 290.082 2
2012 0 8.316.954 912.873 2
2010 0 3.199.995 0 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
ELI LILLY AND COMPANY LIMITED10
PFIZER LIMITED10
NOVARTIS PHARMA9
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT8
JANSSEN PHARMACEUTICA NV8
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD8
KATHOLIEKE UNIVERSITEIT LEUVEN7
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE6
SANOFIAVENTIS DEUTSCHLAND6
UCB BIOPHARMA6
UNIVERSITY OF COPENHAGEN6
LUNDS UNIVERSITET5
SANOFIAVENTIS5
STICHTING KATHOLIEKE UNIVERSITEIT5
UNIVERSITY OF DUNDEE5
ABBVIE INC4
ACADEMISCH ZIEKENHUIS GRONINGEN4
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG4
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE4
H LUNDBECK AS4
JDRF INTERNATIONAL4
KING'S COLLEGE LONDON4
MERCK SHARP & DOHME CORP4
REGION HOVEDSTADEN4
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE4
UNIVERSITE DE LAUSANNE4
UPPSALA UNIVERSITET4
ACADEMISCH ZIEKENHUIS LEIDEN3
BAYER3
EBERHARD KARLS UNIVERSITAET TUEBINGEN3
EUROPEAN PATIENTS' FORUM3
F HOFFMANNLA ROCHE3
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER3
KAROLINSKA INSTITUTE3
MEDIZINISCHE UNIVERSITAET WIEN3
MEDIZINISCHE UNIVERSITAT GRAZ3
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN3
SIB INSTITUT SUISSE DE BIOINFORMATIQUE3
STICHTING VUMC3
TAKEDA DEVELOPMENT CENTRE EUROPE3
THE LEONA M AND HARRY B HELMSLEY CHARITABLE TRUST3
THE UNIVERSITY OF MANCHESTER3
THE UNIVERSITY OF SHEFFIELD3
UNIVERSITA DEGLI STUDI DI MILANO3
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT3
UNIVERSITE LIBRE DE BRUXELLES3
UNIVERSITY OF HELSINKI3
UNIVERSITY OF WALES CARDIFF3
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
ALLERGAN LIMITED2
ANTAROS MEDICAL AB2
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
ASTRAZENECA2
BAYER AKTIENGESELLSCHAFT2
BAYER PHARMA2
BRISTOLMYERS SQUIBB COMPANY CORP2
CENTRE HOSPITALIER DE LUXEMBOURG2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
COVANCE LABORATORIES2
ELLEGAARD GOTTINGEN MINIPIGS AS2
EUROPEAN AIDS TREATMENT GROUP EV2
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
FUJIFILM CELLULAR DYNAMICS INC2
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT2
HANNOVERSCHE KINDERHEILANSTALT2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
INSTITUT DE RECHERCHES SERVIER2
ITASUOMEN YLIOPISTO2
JOHANN WOLFGANG GOETHEUNIVERSITATFRANKFURT AM MAIN2
KOBENHAVNS UNIVERSITET2
LEIDS UNIVERSITAIR MEDISCH CENTRUM2
LIPOTYPE2
OSLO UNIVERSITETSSYKEHUS HF2
OSPEDALE PEDIATRICO BAMBINO GESU2
OULUN YLIOPISTO2
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT2
SLASKI UNIWERSYTET MEDYCZNY W KATOWICACH2
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL2
TECHNISCHE UNIVERSITAET DRESDEN2
TEVA PHARMACEUTICAL INDUSTRIES LIMITED2
THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE2
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA2
THE SYNERGIST2
THE UNIVERSITY OF EXETER2
THE UNIVERSITY OF LIVERPOOL2
UNIVERCELL BIOSOLUTIONS SAS2
UNIVERSITA DEGLI STUDI DI PADOVA2
UNIVERSITA DEGLI STUDI DI SIENA2
UNIVERSITA DEGLI STUDI DI TORINO2
UNIVERSITA DEGLI STUDI GABRIELE D'ANNUNZIO DI CHIETIPESCARA2
UNIVERSITA DI PISA2
UNIVERSITA VITASALUTE SAN RAFFAELE2
UNIVERSITAET ULM2
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ2
UNIVERSITAIR MEDISCH CENTRUM UTRECHT2
UNIVERSITE DE GENEVE2
Constancy:

Total number of partners:562

Partner loyalty:
Frequent Partner: (> 2 projects): 215
Rare Partner: 347

Frequent / Rare Partner Ratio: 0.62

Diversity:

Categories:
Category:No:
RTD HORIZONTAL TOPICS2
INDUSTRY AND TECHNOLOGY1
BIOLOGICAL SCIENCES1

Project overview:

Start dateProjectacronymrolefundingpartners
2021-01-01Surface Integrity for Micro/Nano Processing of Polymers: A European Research Training Network for High-Performance Medical Devices SIMPPER_MedDevparticipant3.294.9178
2020-05-01Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA INNODIA HARVESTparticipant5.999.05540
2020-01-01Novel Strategies for Cell-based Neural Reconstruction NSC-Reconstructparticipant8.168.49513
2020-01-01PharmaLedger PharmaLedgerparticipant8.290.69429
2019-11-01EU Patient- cEntric clinicAl tRial pLatform EU-PEARLparticipant12.004.95336
2019-04-01Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation ConcePTIONparticipant15.299.99153
2019-03-01EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells EBiSC2participant4.599.64816
2019-01-01Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain IM2PACTparticipant9.000.00027
2018-09-01Ensuring the future of EUPATI beyond 2020 EFOEUPATIparticipant365.24312
2018-09-01PET Imaging of Alpha-Synuclein Fibril Formation PET-AlphaSyparticipant4.100.37016
2018-05-01Hypoglycaemia - REdefining SOLutions for better liVEs Hypo-RESOLVEparticipant13.450.05723
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93134
2018-01-01European Research Training to Decipher The Ub Code : identification of potential biomarkers and drug targets UbiCODEparticipant3.407.19420
2017-11-01Liver Investigation: Testing Marker Utility in Steatohepatitis LITMUSparticipant15.797.88156
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-01-01Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 IB4SD-TRISTANparticipant12.000.00021
2016-09-01Unraveling Principles of PDZ-mediated Cell Signaling PDZnetparticipant3.733.51510
2016-09-01Biomarker Enterprise to Attack DKD - Sofia ref.: 115974 BEAt-DKDparticipant15.085.93731
2016-04-01Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881 RHAPSODYparticipant8.130.00027
2015-11-01Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797 INNODIAparticipant17.630.00036
2015-01-01Multi-Stimuli Responsive Molecular Systems and Materials ResMoSysparticipant2.646.3349
2012-09-01A Portable bihormonal Closed Loop for Diabetes PCDIABparticipant4.335.2847
2012-01-01European Training Network for Excellence in Molecular Imaging in Diabetes BetaTrainparticipant3.981.67010
2010-10-01Intelligent and Customized Tooling IC2participant3.199.99516

Alias institution names:
  • NOVO NORDISK

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum